Campylobacter jejuni acquire new host-derived CRISPR spacers when in association with bacteriophages harboring a CRISPR-like Cas4 protein

Frontiers in Microbiology

Volumn 6, Issue JAN, 2015, Pages

  Hooton, Steven P T ^a   Connerton, Ian F ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Bacteriophage; Campylobacter; Carrier state life cycle; Cas4; CRISPR

Indexed keywords

CRISPR ASSOCIATED PROTEIN; GENOMIC DNA; TRANSCRIPTOME;

ARTICLE; BACTERIOPHAGE; BIOINFORMATICS; CAMPYLOBACTER JEJUNI; CRISPR CAS SYSTEM; DNA LIBRARY; DNA SEQUENCE; GENETIC ANALYSIS; GENETIC REGULATION; NONHUMAN; PHYLOGENY; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT;

CAMPYLOBACTER; CAMPYLOBACTER JEJUNI;

EID: 84927513390     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00744     Document Type: Article

References (39)

1. Al-Sayeqh, A. F., Loughlin, M. F., Dillon, E., Mellits, K. H., and Connerton, I. F. (2010). Campylobacter jejuni activates NF-kappaB independently of TLR2, TLR4, Nod1 and Nod2 receptors. Microb. Pathog. 49, 294-304. doi: 10.1016/j.micpath.2010.06.011.
2. Baggerly, K., Deng, L., Morris, J., and Aldaz, C. (2003). Differential expression in SAGE: accounting for normal between-library variation. Bioinformatics 19, 1477-1483. doi: 10.1093/bioinformatics/btg173.
3. Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289-300.
4. Bondy-Denomy, J., Pawluk, A., Maxwell, K. L., and Davidson, A. R. (2013). Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493, 429-432. doi: 10.1038/nature11723.
5. Brathwaite, K. J., Siringan, P., Moreton, J., Wilson, R., and Connerton, I. F. (2013). Complete genome sequence of universal bacteriophage host strain Campylobacter jejuni subsp. jejuni PT14. Genome Announc. 1, e00969-e00913. doi: 10.1128/genomeA.00969-13.
6. Cady, K. C., Bondy-Denomy, J., Heussler, G. E., Davidson, A. R., and O'Toole, G. A. (2012). The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J. Bacteriol. 194, 5728-5738. doi: 10.1128/JB.01184-12.
7. Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., et al. (2009). BLAST+: architecture and applications. BMC Bioinformatics 10:421. doi: 10.1186/1471-2105-10-421.
8. Chylinski, K., Makarova, K. S., Charpentier, E., and Koonin, E. V. (2014). Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res. 42, 6091-6105. doi: 10.1093/nar/gku241.
9. Deveau, H., Barrangou, R., Garneau, J. E., Labonte, J., Fremaux, C., Boyaval, P., et al. (2008). Phage response to CRISPR encoded resistance in Streptococcus thermophilus. J. Bacteriol. 190, 1390-1400. doi: 10.1128/JB.01412-07.
10. Dugar, G., Herbig, A., Förstner, K. U., Heidrich, N., Reinhardt, R., Nieselt, K., et al. (2013). High-resolution transcriptome maps reveal strain-specific regulatory features of multiple Campylobacter jejuni isolates. PLoS Genet. 9:e1003495. doi: 10.1371/journal.pgen.1003495.
11. Fonfara, I., Le Rhun, A., Chylinski, K., Makarova, K. S., Lécrivain, A. L., Bzdrenga, J., et al. (2014). Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res. 42, 2577-2590. doi: 10.1093/nar/gkt1074.
12. Godschalk, P. C., Kuijf, M. L., Li, J., St. Michael, F., Ang, C. W., Jacobs, B. C., et al. (2007). Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect. Immun. 75, 1245-1254. doi: 10.1128/IAI.00872-06.
13. Horvath, P., and Barrangou, R. (2010). CRISPR/Cas, the immune system of bacteria and archaea. Science 327, 167-170. doi: 10.1126/science.1179555.
14. Javed, M. A., Ackermann, H. W., Azeredo, J., Carvalho, C. M., Connerton, I., Evoy, S., et al. (2014). A suggested classification for two groups of Campylobacter myoviruses. Arch. Virol. 159, 181-190. doi: 10.1007/s00705-013-1788-2.
15. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., and Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821. doi: 10.1126/science.1225829.
16. Kelley, L. A., and Sternberg, M. J. E. (2009). Protein structure prediction on the Web: a case study using the Phyre server. Nat. Protoc. 4, 63. doi: 10.1038/nprot.2009.2.
17. Lemak, S., Beloglazova, N., Nocek, B., Skarina, T., Flick, R., Brown, G., et al. (2013). Toroidal structure and DNA cleavage by the CRISPR-associated [4Fe-4S] cluster containing Cas4 nuclease SSO0001 from Sulfolobus solfataricus. J. Am. Chem. Soc. 135, 17476-17487. doi: 10.1021/ja408729b.
18. Loc Carrillo, C., Atterbury, R. J., El-Shibiny, A., Connerton, P. L., Dillon, E., Scott, A., et al. (2005). Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl. Environ. Microbiol. 71, 6554-6563. doi: 10.1128/AEM.71.11.6554-6563.2005.
19. Louwen, R., Horst-Kreft, D., de Boer, A. G., van der Graaf, L., de Knegt, G., Hamersma, M., et al. (2013). A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barre syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 32, 207-226. doi: 10.1007/s10096-012-1733-4.
20. Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J., Charpentier, E., Horvath, P., et al. (2011). Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9, 467-477. doi: 10.1038/nrmicro2577.
21. Marraffini, L. A. (2013). CRISPR-Cas immunity against phages: its effects on the evolution and survival of bacterial pathogens. PLoS Pathog. 9:e1003765. doi: 10.1371/journal.ppat.1003765.
22. Marraffini, L. A., and Sontheimer, E. J. (2010). CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat. Rev. Genet. 11, 181-190. doi: 10.1038/nrg2749.
23. McWilliam, H., Li, W., Uludag, M., Squizzato, S., Park, Y. M., Buso, N., et al. (2013). Analysis Tool Web Services from the EMBL-EBI. Nucleic Acids Res. 41, W597-W600. doi: 10.1093/nar/gkt376.
24. Mortensen, N. P., Kuijf, M. L., Ang, C. W., Schiellerup, P., Krogfelt, K. A., Jacobs, B. C., et al. (2009). Sialylation of Campylobacter jejuni lipooligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes Infect. 11, 988-994. doi: 10.1016/j.micinf.2009.07.004.
25. Saikrishnan, K., Yeeles, J. T., Gilhooly, N. S., Krajewski, W. W., Dillingham, M. S., and Wigley, D. B. (2012). Insights into Chi recognition from the structure of an AddAB-type helicase-nuclease complex. EMBO J. 31, 1568-1578. doi: 10.1038/emboj.2012.9.
26. Sampson, T. R., and Weiss, D. S. (2013). Alternative roles for CRISPR/Cas systems in bacterial pathogenesis. PLoS Pathog. 9:e1003621. doi: 10.1371/journal.ppat.1003621.
27. Seed, K. D., Lazinski, D. W., Calderwood, S. B., and Camilli, A. (2013). A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature 494, 489-491. doi: 10.1038/nature11927.
28. Shah, S. A., Erdmann, S., Mojica, F. J., and Garrett, R. A. (2013). Protospacer recognition motifs: mixed identities and functional diversity. RNA Biol. 10, 891-899. doi: 10.4161/rna.23764.
29. Sheppard, S. K., McCarthy, N. D., Falush, D., and Maiden, M. C. (2008). Convergence of Campylobacter species: implications for bacterial evolution. Science 320, 237-239. doi: 10.1126/science.1155532.
30. Siringan, P., Connerton, P. L., Cummings, N. J., and Connerton, I. F. (2014). Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni. Open Biol. 4:130200. doi: 10.1098/rsob.130200.
31. Sisáková, E., Stanley, L. K., Weiserová, M., and Szczelkun, M. D. (2008). A RecB-family nuclease motif in the Type I restriction endonuclease EcoR124I. Nucleic Acids Res. 36, 3939-3949. doi: 10.1093/nar/gkn333.
32. Sorek, R., Lawrence, C. M., and Wiedenheft, B. (2013). CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu. Rev. Biochem. 82, 237-266. doi: 10.1146/annurev-biochem-072911-172315.
33. Spilman, M., Cocozaki, A., Hale, C., Shao, Y., Ramia, N., Terns, R., et al. (2013). Structure of an RNA silencing complex of the CRISPR-Cas immune system. Mol. Cell. 52, 146-152. doi: 10.1016/j.molcel.2013.09.008.
34. Stern, A., Keren, L., Wurtzel, O., Amitai, G., and Sorek, R. (2010). Self-targeting by CRISPR: gene regulation or autoimmunity? Trends Genet. 26, 335-340. doi: 10.1016/j.tig.2010.05.008.
35. Sun, C. L., Barrangou, R., Thomas, B. C., Horvath, P., Fremaux, C., and Banfield, J. F. (2013). Phage mutations in response to CRISPR diversification in a bacterial population. Environ. Microbiol. 15, 463-470. doi: 10.1111/j.1462-2920.2012.02879.x.
36. Vercoe, R. B., Chang, J. T., Dy, R. L., Taylor, C., Gristwood, T., Clulow, J. S., et al. (2013). Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet. 9:e1003454. doi: 10.1371/journal.pgen.1003454.
37. Yosef, I., Goren, M. G., and Qimron, U. (2012). Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res. 40, 5569-5576. doi: 10.1093/nar/gks216.
38. Zegans, M. E., Wagner, J. C., Cady, K. C., Murphy, D. M., Hammond, J. H., and O'Toole, G. A. (2009). Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa. J. Bacteriol. 191, 210-219. doi: 10.1128/JB.00797-08.
39. Zhang, J., Kasciukovic, T., and White, M. F. (2012). The CRISPR associated protein Cas4 is a 5' to 3' DNA exonuclease with an iron-sulfur cluster. PLoS ONE 7:e47232. doi: 10.1371/journal.pone.0047232.